What We Do
CIBMTR has a broad range of research activities, but our focus is narrow. Patients. They are the reason CIBMTR exists. Patients count on us to discover and apply the best therapies that research has identified, and to never let up in our efforts to improve those therapies.
Learn how we collaborate worldwide to help more patients.
Lead and conduct research studies
Collect and maintain outcomes data
Provide access to outcomes data
Provide access to research repository samples
Provide statistical expertise to researchers
Provide education, guidelines and training
Lead and conduct research studies
CIBMTR leads a worldwide collaboration of scientists and clinicians to advance understanding and outcomes of hematopoeitic cell transplantation (HCT). This research helps assess donor safety and helps identify the most promising transplant approaches and the patients most likely to benefit from this therapy.
Collect and maintain outcomes data
We collect outcomes data on every allogeneic transplantation performed in the U.S. (for the SCTOD, as required by U.S. law). U.S. transplant centers also voluntarily submit autologous transplantation data, and transplant centers worldwide voluntarily submit both autologous and allogeneic transplantation data. As a result, our clinical database now contains information on more than 300,000 transplant recipients.
Provide access to outcomes data
Collected data can be accessed for patient care decisions, developing research studies, education, transplant center administrative needs, and CIBMTR research.
Provide access to research repository samples
The NMDP Research Sample Repository contains more than 19,000 related and unrelated paired transplant recipient/donor (or cord blood) samples with complete, validated clinical data. Samples can be used for local research studies, or for CIBMTR research studies.
Provide statistical expertise to researchers
Both new and experienced investigators have access to biostatistical support to write study proposals, and develop protocols.
Provide education, guidelines and training
CIBMTR provides trends, outcomes data and presentation graphics, develops post-transplant care guidelines and conducts meetings for education, science and training. The CIBMTR has published more than 500 peer-reviewed papers in the medical literature since 1972.
